Download by
Scanning QR Code
No Stock Yet
No Data
Vericel Co. (NASDAQ:VCEL) Shares Acquired by GW&K Investment Management LLC
GW&K Investment Management LLC lifted its holdings in shares of Vericel Co. (NASDAQ:VCEL – Get Rating) by 169.9% in the 1st quarter, according to the company in its most recent 13F filing with t
Vericel (NASDAQ:VCEL) Shares Gap Down to $31.81
Shares of Vericel Co. (NASDAQ:VCEL – Get Rating) gapped down prior to trading on Wednesday . The stock had previously closed at $31.81, but opened at $29.85. Vericel shares last traded at $33.27, wit
Vericel Q2 Net Loss Widens as Revenue Declines; Full-Year Sales Outlook Maintained
09:32 AM EDT, 08/03/2022 (MT Newswires) -- Vericel (VCEL) reported a Q2 net loss Wednesday of $0.19 per diluted share, widening from a loss of $0.08 a year earlier. Five analysts polled by Capital IQ
Vericel GAAP EPS of -$0.19 misses by $0.07, revenue of $37.05M misses by $1.3M
Vericel press release (NASDAQ:VCEL): Q2 GAAP EPS of -$0.19 misses by $0.07. Revenue of $37.05M (-6.3% Y/Y) misses by $1.3M. FY2022 Outlook: Total revenue guidance maintained at $178M to $189M vs.
MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review
The U.S. Food and Drug Administration (FDA) accepted for review MediWound's (NASDAQ:MDWD) re-submitted biologics license application (BLA) seeking approval of NexoBrid for eschar (dead tissue) removal
Vericel 2Q Rev $37M >VCEL
Vericel 2Q Rev $37M >VCEL
Vericel 2Q Loss/Shr 19c >VCEL
Vericel 2Q Loss/Shr 19c >VCEL
Press Release: Vericel Reports Second Quarter 2022 Financial Results
Vericel Reports Second Quarter 2022 Financial Results Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Ma
Vericel Q2 2022 Earnings Preview
Vericel (NASDAQ:VCEL) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is -$0.12 (-50.0% Y/Y) and the consensus Revenue Estimate is
Vericel publishes BRCA study results of burn patients treated with Epicel
Vericel Corporation announced the publication of results from a retrospective study conducted by the Burn and Reconstructive Centers of America of 40 patients with large posterior trunk burns treated
Loading...
No Stock Yet